Alan Lumsden, MD Walter W. Fondren III Presidential Distinguished Chair, DeBakey Heart & Vascular Center Chair, Department of ...

Inquis Medical announced today that it completed enrollment in a pivotal trial evaluating its Aventus thrombectomy system.

Argon Medical Devices announced the first patient enrollment in the CLEAN-PE study, which is estimated to enroll > 100 patien ...

ultrasound-assisted (EKOS Endowave®) Serious DVT and/or PE Directs iv ... [24,36] Percutaneous mechanical thrombectomy (Trerotola and Angiojet®) When thrombolytics are absolutely contraindicated ...

The multicenter study is led by National Principal Investigator Dr. Aravinda Nanjundappa, MD, an Interventional Cardiologist at the Cleveland Clinic in Cleveland, Ohio. The first patient procedure ...

The prospective, multicenter CLEAN-PE study aims to evaluate the safety and efficacy of the Cleaner™ Pro Thrombectomy System for removing blood clot from the lungs in patients diagnosed with ...

Thrombectomy Devices Market Drivers: . The growing prevalence of conditions like DVT, PE, and ischemic strokes increases demand for thrombectomy devices. . Innovations in thrombectomy devices ...

The article, “Novel Mechanical Aspiration Thrombectomy in Patients with Acute Pulmonary Embolism: Results from the Prospective APEX-AV Trial,” was published December 27, 2024. Pulmonary ...

With full enrollment completed, the company is one step closer to demonstrating the potential of the Aventus Thrombectomy System to revolutionize PE treatment. “This trial is a key step toward ...